menu
    • menu

    Company profile for BASF

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of app...
    We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of approximately €6.7 billion. We combine economic success with environmental protection and social responsibility. Through research and innovation, we support our customers in nearly every industry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BASFGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Carl-Bosch-Strasse 38 Ludwigshafen , Rhineland-Palatinate 67056
    Telephone
    Telephone
    +49-(0)-621-600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharmaceutical.basf.com/global/en.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/basf-pharma-solutions/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BASF_Pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI South East Asia

    Not Confirmed

    envelop Contact Supplier

    CPhI South East Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 1245

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaProviding RSMs & API to Global Pharma CompaniesProviding RSMs & API to Global Pharma Companies

    Providing RSMs & API to Global Pharma Companies
    Providing RSMs & API to Global Pharma Companies

    reelProviding RSMs & API to Global Pharma Companies

    This PharmaReel showcases Allsino Pharmaceutical, a company that provides GMP-certified RSMs and APIs to global pharma companies, specializing in peptides, oligonucleotides, and small molecule CDMO services. Allsino has a presence in the US, EU, China and Japan.

    Impressions: 1352

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    The pharmaceutical industry has witnessed a wave of mergers, acquisitions, and strategic partnerships so far in the first half (H1) of 2025, with deal values exceeding US$ 170 billion.PharmaCompass’ data shows oncology alone accounted for nearly US$ 47 billion in deal value, followed by US$ 18 billion each in immunology and psychiatry, US$ 17 billion in nutrition/weight loss and US$ 7 billion in neurology.Pharma majors such as Johnson & Johnson and Bristol Myers Squibb led with two deals worth over US$ 10 billion each. Sanofi executed a series of deals in the immunology and neuro-inflammation space. And Eli Lilly stood out for its aggressive dealmaking, which spanned oncology, pain, RNA therapies, and AI-driven oligonucleotides. In all, it signed seven deals worth over US$ 1 billion each. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available)H1 records several mega deals as J&J buys Intra-Cellular, BMS ties up with BioNTech, Sanofi acquires BlueprintJohnson & Johnson dominated headlines with its US$ 14.6 billion acquisition of Intra-Cellular Therapies in January 2025. This marks the largest biopharma deal since Novo Nordisk’s US$ 16.5 billion acquisition of Catalent in February 2024. This acquisition positions J&J as a formidable player in the neuroscience space. Bristol Myers Squibb entered into a US$ 11.1 billion partnership with BioNTech. The deal structure — US$ 3.5 billion in unconditional payments and up to US$ 7.6 billion in milestone payments — demonstrates BMS’ confidence in BNT327, a next-generation bispecific antibody in phase 3 trials for treating extensive stage small cell lung cancer and non-small cell lung cancer.Sanofi acquired Blueprint Medicines for US$ 9.5 billion in order to enhance its rare disease portfolio. The French drugmaker is also creating a comprehensive immunology portfolio. The company signed a US$ 1.9 billion deal for Dren Bio’s DR-0201 bispecific antibody for autoimmune diseases. Sanofi also acquired Vigil Neuroscience for US$ 470 million for its phase 2-ready Alzheimer’s disease candidate. Additionally, the drugmaker secured a US$ 1.84 billion global license agreement with Earendil Labs for two next-generation bispecific antibodies.Pfizer’s US$ 6.05 billion partnership with 3SBio provides it global licensing rights (excluding China) for SSGJ-707, a bispecific antibody currently undergoing multiple clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Obesity gold rush sees Roche, AbbVie, Sciwind ink deals; Novo pledges over US$ 5 bn across three dealsThe obesity therapeutics market has triggered intense competition among pharmaceutical giants. Roche’s US$ 5.3 billion partnership with Zealand Pharma is focused on petrelintide, an amylin analog designed to preserve lean mass better than existing GLP-1-based treatments. The collaboration combines petrelintide with Roche’s dual GLP-1/GIP receptor agonist CT-388, creating a differentiated obesity treatment.Market leader Novo Nordisk has promised over US$ 5 billion across three major obesity deals in 2025. The US$ 2.2 billion Septerna collaboration targets oral small molecule medicines for obesity and cardiometabolic diseases.Novo signed a separate US$ 2 billion agreement with China’s United Biotechnology for UBT251, a triple agonist for GLP-1, GIP, and glucagon receptors in phase 2 clinical development for obesity, type 2 diabetes, and other diseases. The company’s third major deal, a US$ 1 billion partnership with Lexicon Pharmaceuticals, provides it access to LX9851, a molecule in preclinical development for obesity and associated metabolic disorders.Sciwind Biosciences secured a US$ 2.5 billion global licensing and collaboration agreement with Verdiva Bio Limited for the global development and commercialization of a portfolio of metabolic diseases therapies. AbbVie entered the amylin arena through its US$ 2.2 billion Gubra partnership for GUB014295, a candidate in phase 1 trials for treating obesity. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Molecular glue degraders draw investments; Lilly signs seven deals over US$ 1 billion eachMolecular glue degraders have emerged as a transformative therapeutic modality, attracting significant investment across multiple partnerships. AbbVie’s US$ 1.64 billion collaboration with Neomorph leverages the biotech’s leading molecular glue discovery platform for oncology and immunology applications.Genentech’s potential US$ 2.1 billion partnership with Orionis Biosciences focuses on small-molecule monovalent glue medicines for novel and challenging oncology targets. This is the second partnership between the two companies, following their initial 2023 collaboration.Eli Lilly has collaborated with Magnet Biomedicine, utilizing Magnet’s TrueGlue discovery platform for oncology applications. The deal could be worth up to US$ 1.3 billion.Eli Lilly has emerged as one of 2025’s most active dealmakers, with approximately seven deals exceeding US$ 1 billion each. The company’s US$ 2.5 billion Scorpion Therapeutics acquisition provides access to STX-478, an experimental oral therapy in early-stage trials for breast cancer and advanced solid tumors, potentially addressing 30 to 40 percent of hormone-positive breast cancer patients.On June 17, Lilly announced the acquisition of gene-editing startup Verve Therapeutics for US$ 1.3 billion. Lilly’s US$ 1 billion SiteOne acquisition announced in May brings STC-004, a phase 2-ready non-opioid chronic pain treatment to its pipeline. Other partnerships announced by Lilly include a US$ 1.4 billion capsid licensing deal with Sangamo for central nervous system disease genomic medicines and a US$ 1.3 billion collaboration with South Korean company Rznomics for RNA-based hearing loss treatments. Lilly has also strengthened its oligonucleotide pipeline through a potential US$ 1 billion collaboration with Creyon Bio for AI-designed oligonucleotide therapies targeting RNA. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Merck KGaA acquires SpringWorks for US$ 3.9 bn; Novartis buys out Anthos for US$ 3.1 bnAstraZeneca signed a US$ 5.3 billion AI-led research agreement with China’s CSPC Pharmaceuticals Group to advance the discovery of novel oral candidates for immunological diseases. Merck KGaA acquired SpringWorks for US$ 3.9 billion in April, which gave it access to two FDA-approved therapies — Ogsiveo (nirogacestat), the first and only approved therapy for adult patients with progressing desmoid tumors requiring systemic treatment, and Gomekli (mirdametinib), the first and only FDA-approved therapy for adults and children with neurofibromatosis type 1-associated plexiform neurofibromas.Novartis’ US$ 3.1 billion Anthos Therapeutics acquisition centered around abelacimab, a potential first-in-class monoclonal antibody currently in three phase 3 studies for stroke and systemic embolism prevention in atrial fibrillation patients.GSK’s US$ 2 billion acquisition of Boston Pharmaceuticals’ efimosfermin targets steatotic liver disease (fatty liver disease). The medicine is also in clinical development for MASH treatment. GSK’s second major deal involved the US$ 1.15 billion acquisition of US biotech IDRx, strengthening its gastrointestinal cancer portfolio.The pharma industry also drew some private equity interest as Bain Capital acquired Japan’s Mitsubishi Tanabe Pharma from Mitsubishi Chemical Group for US$ 3.3 billion. View Pharma & Biotech Acquisitions, Deals & Agreements in 2025 as of June 14 (Free Excel Available) Our viewDespite an uncertain geopolitical environment, the year has seen a surge in M&As and dealmaking in the first half of 2025. However, a sizable chunk of the acquisitions were bolt-on transactions, indicating that companies are not ready to take on risks, and are buying out smaller players who strategically fit into their operations. Going forward, there are indications that M&A activity will stay strong throughout 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2808

    https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025

    #PharmaFlow by PHARMACOMPASS
    19 Jun 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    BASF opens new GMP Solution Center in US
    BASF opens new GMP Solution Center in US

    23 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/basf-opens-new-gmp-solution-center-in-us-17301

    INDPHARMAPOST
    23 Jun 2025
    Share Share
    KFSHRC Detects 276 Fetal Disorders, Saving SAR 360M Annually
    KFSHRC Detects 276 Fetal Disorders, Saving SAR 360M Annually

    10 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/10/3023415/0/en/KFSHRC-Detects-276-Fetal-Genetic-Disorders-Through-Prenatal-Care-Saving-SAR-360-Million-Annually.html

    GLOBENEWSWIRE
    10 Feb 2025
    Share Share
    BASF Sells Food & Health Performance Ingredients to Louis Dreyfus
    BASF Sells Food & Health Performance Ingredients to Louis Dreyfus

    24 Dec 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/basf-sells-food-and-health-performance-ingredients-business-to-louis-dreyfus-company-16572

    INDPHARMAPOST
    24 Dec 2024
    Share Share
    BASF Introduces Pepsensyal Peptide For Slow-Aging Skin Care
    BASF Introduces Pepsensyal Peptide For Slow-Aging Skin Care

    23 Oct 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/basf-introduces-pepsensyal-peptide-for-slow-aging-skin-care-solutions/

    EXPRESSPHARMA
    23 Oct 2024
    Share Share
    BASF to prepare agricultural business for IPO, Bloomberg reports
    BASF to prepare agricultural business for IPO, Bloomberg reports

    18 Sep 2024

    // REUTERS

    https://www.reuters.com/markets/europe/basf-expected-announce-listing-plans-agri-chemicals-division-reports-bloomberg-2024-09-18/

    REUTERS
    18 Sep 2024
    Share Share
    German chemical sector employers, union agree 6.85% pay hike over 20 months
    German chemical sector employers, union agree 6.85% pay hike over 20 months

    27 Jun 2024

    // REUTERS

    https://www.reuters.com/markets/commodities/german-chemical-sector-employers-union-agree-685-pay-hike-over-20-months-2024-06-27/

    REUTERS
    27 Jun 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    5-ethenyl-pyrrolidin-2-one

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    02

    7,-8-didehydro-retinoic Acid

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    03

    9-z-isotretinoin

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    04

    Acetaminophen

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    05

    Acetohexamide

    Switzerland
    Discovery Europe
    Not Confirmed
    arrow

    06

    Acitretin

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    07

    Allopurinol

    Switzerland
    Discovery Europe
    Not Confirmed
    arrow

    08

    Amsacrine

    Switzerland
    Discovery Europe
    Not Confirmed
    arrow

    09

    Ascorbic Acid

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    10

    Beta-carotene (25mg.) Soft Gelatin C...

    Germany
    Discovery Europe
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    KDMF

    read-more
    read-more

    01

    Calcium pantothenate

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Calcium pantothenate

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2022-05-02

    Registration Number : 20220502-211-J-1281

    Manufacturer Name : BASF SE

    Manufacturer Address : Carl-Bosch-Strasse 38, 67056 Ludwigshafen, Germany

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    02

    Calcium pantothenate

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Calcium pantothenate

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : Parmarine Co., Ltd.

    Registration Date : 2025-05-12

    Registration Number : 20220502-211-J-1281(1)

    Manufacturer Name : BASF SE

    Manufacturer Address : Carl-Bosch-Strasse 38, 67056 Ludwigshafen, Germany

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    03

    Ibuprofen

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Ibuprofen

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : Parmarine Co., Ltd.

    Registration Date : 2024-12-23

    Registration Number : 20220725-209-J-1335(1)

    Manufacturer Name : BASF Corporation

    Manufacturer Address : Highway 77 South, Bishop, Texas 78343 (5738 County Road 4, Bishop, Texas 78343), USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    04

    Ibuprofen

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Ibuprofen

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2022-07-25

    Registration Number : 20220725-209-J-1335

    Manufacturer Name : BASF Corporation

    Manufacturer Address : Highway 77 South, Bishop, Texas 78343 (5738 County Road 4, Bishop, Texas 78343) USA

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    05

    Omega 3 acid ethyl ester 90

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Omega 3 acid ethyl ester 90

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : BASF Korea Ltd.

    Registration Date : 2012-12-27

    Registration Number : No. 6246-1-ND

    Manufacturer Name : BASF Pharma (Callanish) Ltd

    Manufacturer Address : Breasclete, Callanish, Isle of Lewis, HS2 9ED, Scotland

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    06

    Omega-3 acid ethyl ester

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Omega-3 acid ethyl ester

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : Geonil Pharmaceutical Co., Ltd.

    Registration Date : 2005-09-08

    Registration Number : 38-1-ND

    Manufacturer Name : BASF AS

    Manufacturer Address : Framnesveien 41, SANDEFJORD, NO-3222, Norway

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    07

    Tocopherol acetate

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Tocopherol acetate

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Registrant Name : Parmarine Co., Ltd.

    Registration Date : 2024-08-09

    Registration Number : 20240809-211-J-1635

    Manufacturer Name : BASF SE

    Manufacturer Address : Carl-Bosch-Strasse 38, 67056 Ludwigshafen, Germany

    blank

    Product
    Web Link

    Stock Recap
    #Pipeline Prospector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Brand Name : IBU

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : IBU

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : IBU

    Dosage Strength : 400MG

    Packaging :

    Approval Date : 1982-01-01

    Application Number : 18197

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : IBU

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : IBU

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : IBU

    Dosage Strength : 400MG

    Packaging :

    Approval Date : 1985-02-22

    Application Number : 70083

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : IBU

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : IBU

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : IBU

    Dosage Strength : 600MG

    Packaging :

    Approval Date : 1985-03-29

    Application Number : 70099

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : RUFEN

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : RUFEN

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : RUFEN

    Dosage Strength : 600MG

    Packaging :

    Approval Date : 1984-03-05

    Application Number : 18197

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : IBU

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : IBU

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : IBU

    Dosage Strength : 600MG

    Packaging :

    Approval Date : 1985-02-08

    Application Number : 70088

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : IBU

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : IBU

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : DISCN

    Registration Country : USA

    IBUPROFEN

    BASF

    Dosage Form : TABLET;ORAL

    Brand Name : IBU

    Dosage Strength : 800MG

    Packaging :

    Approval Date : 1986-07-23

    Application Number : 70745

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Omacor

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Brand Name : Omacor

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info :

    Registration Country : Norway

    Omega-3 acid ethyl esters 90

    BASF

    Dosage Form : Kapsel, myk

    Brand Name : Omacor

    Dosage Strength : 1000 mg

    Packaging : Boks av plast 98item

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    All Excipients

    read-more
    read-more

    01

    Crospovidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Crospovidone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 2855

    Submission : 1977-02-08

    Status : Active

    Type : IV

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-076 - Rev 01

    Issue Date : 2015-06-26

    Type :

    Substance Number :

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Povidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Povidone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 22604

    Submission : 2009-01-19

    Status : Active

    Type : IV

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-079 - Rev 01

    Issue Date : 2017-02-09

    Type :

    Substance Number :

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Povidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Povidone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 32695

    Submission : 2018-03-27

    Status : Active

    Type : IV

     CEP/COS Inactive-api
    ✖

    Certificate Number : R1-CEP 2007-078 - Rev 01

    Issue Date : 2017-01-30

    Type :

    Substance Number :

    Status : Withdrawn by Holder

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Povidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Povidone

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11070

    Submission : 1994-08-30

    Status : Inactive

    Type : IV

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-077 - Rev 02

    Issue Date : 2017-01-30

    Type :

    Substance Number :

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Cocoyl Caprylocaprate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Cocoyl Caprylocaprate

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16496

    Submission : 2003-03-25

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Medium Chain Triglycerides Excipien...

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Medium Chain Triglycerides Excipien...

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16495

    Submission : 2003-03-25

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Methacrylic Acid - Ethyl Acrylate C...

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Methacrylic Acid - Ethyl Acrylate C...

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14823

    Submission : 2000-04-11

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Octyldodecanol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Octyldodecanol

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16494

    Submission : 2003-03-25

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Oleyl Alcohol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Oleyl Alcohol

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16497

    Submission : 2003-03-25

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Polyvinyl Acetate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Discovery Europe
    Not Confirmed
    arrow

    Polyvinyl Acetate

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15055

    Submission : 2000-09-20

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    KOLLICOAT MAE 30DP

    Discovery Europe
    Not Confirmed
    arrow

    02

    KOLLICOAT SMARTSEAL 30 D

    Discovery Europe
    Not Confirmed
    arrow

    03

    KOLLICOATE¨ MAE 100 P

    Discovery Europe
    Not Confirmed
    arrow

    04

    KOLLICOAT® IR

    Discovery Europe
    Not Confirmed
    arrow

    05

    KOLLICOAT® PROTECT

    Discovery Europe
    Not Confirmed
    arrow

    06

    KOLLICOAT® SMARTSEAL 100 P

    Discovery Europe
    Not Confirmed
    arrow

    07

    KOLLICOAT® SR 30 D

    Discovery Europe
    Not Confirmed
    arrow

    08

    KOLLICREAM® 3C

    Discovery Europe
    Not Confirmed
    arrow

    09

    KOLLICREAM® CI

    Discovery Europe
    Not Confirmed
    arrow

    10

    Kollicream® CP 15

    Discovery Europe
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Copovidone, Nominal K-value 28

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    02

    Crospovidone, Type A and B

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    03

    Macrogol 15 hydroxystearate

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Macrogol 15 hydroxystearate

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Certificate Numbers : R1-CEP 2006-095 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2018-06-08

    Type : Chemical

    Substance Number : 2052

    blank

    Excipients Web Link

    Market Place

    04

    Povidone, 'Nominal K-value 12' and 'nomi...

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    05

    Povidone, 'Nominal K-value 25' and 'nomi...

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    06

    Povidone, 'Nominal K-value 90'

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Povidone, 'Nominal K-value 90'

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Certificate Numbers : R1-CEP 2007-078 - Rev 01

    Status : Withdrawn by Holder

    Issue Date : 2017-01-30

    Type : Chemical

    Substance Number : 685

    blank

    Excipients Web Link

    Market Place

    07

    Povidone, iodinated

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    Povidone, iodinated

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    Certificate Numbers : R1-CEP 2008-179 - Rev 00

    Status : Valid

    Issue Date : 2015-10-21

    Type : Chemical

    Substance Number : 1142

    blank

    Excipients Web Link

    Market Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    NDC API

    read-more
    read-more

    01

    POLYETHYLENE GLYCOL 3350

    Germany
    Discovery Europe
    Not Confirmed
    arrow

    POLYETHYLENE GLYCOL 3350

    Germany
    arrow
    Discovery Europe
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    BASF

    NDC Package Code : 70177-0001

    Start Marketing Date : 2007-10-03

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    blank

    Excipients Web Link

    Market Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Excipients by Ingredients

    Upload your portfolio for free, ask us

    Povidone

    read-more
    read-more

    01

    Brand Name : Kollidon 12 PF

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    02

    Brand Name : Kollidon 17 PF

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    03

    Brand Name : Kollidon 25

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    04

    Brand Name : Kollidon 30

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    05

    Brand Name : Kollidon 30 LP

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    06

    Brand Name : Kollidon 90 F

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    07

    Brand Name : Kollidon SR

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    08

    Brand Name : Ludipress

    Germany

    arrow
    Discovery Europe
    Not Confirmed

    09

    Brand Name : Ludipress LCE

    Germany

    arrow
    Discovery Europe
    Not Confirmed
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients By applications

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact BASF SE and get a quotation

    BASF SE is a supplier offers 65 products (APIs, Excipients or Intermediates).

    Find a price of Ibuprofen bulk with DMF, CEP, JDMF offered by BASF SE

    Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF, CEP, JDMF offered by BASF SE

    Find a price of Riboflavin bulk with CEP, JDMF offered by BASF SE

    Find a price of Vitamin E Acetate bulk with CEP, JDMF offered by BASF SE

    Find a price of Icosapent Ethyl bulk with DMF, JDMF offered by BASF SE

    Find a price of Levomenthol bulk with DMF, CEP offered by BASF SE

    Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF, CEP offered by BASF SE

    Find a price of Povidone Iodine bulk with DMF, JDMF offered by BASF SE

    Find a price of Riboflavin bulk with JDMF offered by BASF SE

    Find a price of Vitamin A bulk with CEP offered by BASF SE

    Find a price of Vitamin E bulk with CEP offered by BASF SE

    Find a price of 2-Phenoxyethanol bulk with CEP offered by BASF SE

    Find a price of Acitretin bulk offered by BASF SE

    Find a price of Ascorbic Acid bulk offered by BASF SE

    Find a price of Azelaic Acid bulk with DMF offered by BASF SE

    Find a price of D-Panthenol bulk with CEP offered by BASF SE

    Find a price of Detalan bulk with DMF offered by BASF SE

    Find a price of Ibuprofen bulk with DMF offered by BASF SE

    Find a price of Ibuprofen Sodium bulk with DMF offered by BASF SE

    Find a price of Menthol bulk with JDMF offered by BASF SE

    Find a price of Octocrylene bulk with DMF offered by BASF SE

    Find a price of Omega-3-Acid Ethyl Esters 90 bulk with DMF offered by BASF SE

    Find a price of Pantothenic Acid bulk with CEP offered by BASF SE

    Find a price of Polyethylene Glycol Monostearate bulk with DMF offered by BASF SE

    Find a price of Triclosan bulk with DMF offered by BASF SE

    Find a price of Vitamin D3 bulk with DMF offered by BASF SE

    Find a price of 5-Ethenyl-Pyrrolidin-2-One bulk offered by BASF SE

    Find a price of Benzoic Acid bulk offered by BASF SE

    Find a price of Beta Carotene bulk offered by BASF SE

    Find a price of Calcium Ascorbate bulk offered by BASF SE

    Find a price of DHA bulk offered by BASF SE

    Find a price of Diethylhexyl Phthalate bulk offered by BASF SE

    Find a price of Doxazosin Mesylate bulk offered by BASF SE

    Find a price of Fluoxetine Hydrochloride bulk offered by BASF SE

    Find a price of Hexanedioic Acid, Polymer With 1,6-Hexanediol bulk offered by BASF SE

    Find a price of Isotretinoin bulk offered by BASF SE

    Find a price of Macrogol bulk offered by BASF SE

    Find a price of Paracetamol bulk offered by BASF SE

    Find a price of Pyridoxine Hydrochloride bulk offered by BASF SE

    Find a price of Riboflavin bulk offered by BASF SE

    Find a price of Sibutramine Hydrochloride bulk offered by BASF SE

    Find a price of Sodium Ascorbate bulk offered by BASF SE

    Find a price of Tazarotene bulk offered by BASF SE

    Find a price of Terazosin HCl bulk offered by BASF SE

    Find a price of Thiamine Hydrochloride bulk offered by BASF SE

    Find a price of Thiamine Mononitrate bulk offered by BASF SE

    Find a price of Tretinoin bulk offered by BASF SE

    Find a price of Vitamin A Acetate bulk offered by BASF SE

    Find a price of Vitamin A Palmitate bulk offered by BASF SE

    Find a price of Vitamin D3 bulk offered by BASF SE

    Find a price of Vitamin E bulk offered by BASF SE

    Find a price of STERILE AREA 1 DEPARTMENT AT MONZA FACILITY IN MILAN, ITALY. bulk offered by BASF SE

    Find a price of KOLLIDON 12 PF, POLYVINYLPYRROLIDONE bulk offered by BASF SE

    Find a price of UVINUL N539 SG bulk offered by BASF SE

    Find a price of RADIO-PHARMACEUTICAL SYNTHESIS MODULE << SYNTHERArV1 >> bulk offered by BASF SE

    Find a price of GLUCOPONA(R) 600 UP bulk offered by BASF SE

    Find a price of N-[1-(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL 2-NAPHTHALENYL) bulk offered by BASF SE

    Find a price of LUROTIN TM CAPSULES bulk offered by BASF SE

    Find a price of MFG SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR OSLO NORWAY bulk offered by BASF SE

    Find a price of Bronopol bulk offered by BASF SE

    Find a price of Calcium Pantothenate bulk offered by BASF SE

    Find a price of Ibuprofen bulk offered by BASF SE

    Find a price of Ibuprofen Lysinate bulk offered by BASF SE

    Find a price of Levomenthol bulk offered by BASF SE

    Find a price of Zinc Oxide bulk offered by BASF SE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search